Lifevantage Corporation  

(Public, NASDAQ:LFVN)   Watch this stock  
Find more results for LFVN
2.37
-0.07 (-2.87%)
Real-time:   2:16PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.35 - 2.43
52 week 1.60 - 3.85
Open 2.40
Vol / Avg. 290,275.00/442,973.00
Mkt cap 269.56M
P/E 92.51
Div/yield     -
EPS 0.03
Shares 113.74M
Beta 1.48
Inst. own 4%
May 9, 2013
Q3 2013 Lifevantage Corp Earnings Conference Call
Mar 18, 2013
Lifevantage Corp at Roth Conference
Feb 28, 2013
Lifevantage Corp at Accredited Members Small Cap/Micro Cap Investment Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 0.39% 9.88%
Operating margin 0.91% 17.00%
EBITD margin - 17.42%
Return on average assets 1.60% 43.73%
Return on average equity 2.42% 333.62%
Employees 81 -
Carbon Disclosure Rating - -

Address

Suite 100, 9815 S. Monroe Street
SANDY, UT 84070
United States - Map
+1-801-4329000 (Phone)
+1-801-2063800 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Lifevantage Corporation (Lifevantage) is engaged in the identification, research, development, manufacture and distribution of advanced nutraceutical dietary supplements, including its product, Protandim, the Nrf2 Synergizer and its anti-aging skin care product, LifeVantage TrueScience. The Company focuses its ongoing internal research efforts on oxidative stress solutions, particularly the activation of nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as it relates to health-related disorders. The Company provides products and network marketing business opportunity to customers and independent distributors. The Company sells its products in the United States, Japan, Australia and Mexico through a network of independent distributors, and to preferred and retail customers. The Company also sells its products directly to consumers located in Canada for personal consumption.

Officers and directors

Elwood H. Spedden Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Douglas C. Robinson President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
David Colbert Chief Financial Officer
Age: 43
Bio & Compensation  - Reuters
David W. Brown President - LifeVantage Network, Director
Age: 49
Bio & Compensation  - Reuters
Robert Urban Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Ryan Thompson Senior Vice President - Sales
Age: 42
Bio & Compensation  - Reuters
Eugene Tipps Senior Vice President - Operations
Bio & Compensation  - Reuters
Darlene R. Walley Ph.D. Chief Science Officer
Bio & Compensation  - Reuters
Robert H. Cutler General Counsel, Corporate Secretary
Age: 44
Bio & Compensation  - Reuters
Kirby L. Zenger Chief Network Officer
Age: 58
Bio & Compensation  - Reuters